ABG Commercial Realty  |  (617) 492 9900

View Saved Properties  |   Sign Up

Vitro ADMET Laboratories Purchases Biomedical Testing Facility in Malden

Please enter your starting address in the form input below.

Transaction Description

ABG Realty recently represented the seller in the transaction of 389 Main Street in Malden for $385,500. Thayer Morgan of Century 21 represented the property's buyer, In Vitro ADMET Laboratories LLC. 7,236 square feet of office and lab space was sold to the Maryland-based pharma company. In Vitro offers products and contract services that represent three decades of expertise in the application of in vitro experimental systems to evaluate drug absorption, metabolism, drug-drug interactions and drug toxicity.

IVAL intends to use the space at 389 Main St as a new biomedical testing facility. Conveniently situated in the heart of the Malden Center, this building is easily accessible by MBTA public transport, making it easy for employees to commute to work. In Vitro is excited about its new testing location, which it hopes will further expedite the drug development process. By offering a new location for drug testing, the company will look to improve the efficiency of this aspect of its business so it can focus more on areas such as R&D.

Space Available

If you would like to send this property to a friend that you think may be interested, please complete the form below. To send this property to multiple friends, enter each email separated by a comma in the 'Friends Email' field.

Please complete the form below to request a showing for this property. We will review your request and respond to you as soon as possible. Please add any additional notes or comments that we will need to know about your request.

Listing Agent

Toni Shelzi

  • ABG Commercial Realty
  • This email address is being protected from spambots. You need JavaScript enabled to view it.
  • (617) 492-9900
Contact Agent
This website uses cookies to improve your experience. By clicking accept and continuing on this site, you consent to our use of cookies. Read more in our privacy policy.